Background: Heavy alcohol consumption in individuals with type 2 diabetes mellitus (T2DM) is related to increased risks of diabetes-related micro-and macrovascular complications. Depressive symptoms may be relevant to this relationship, because high depressive symptoms are associated with an increased risk of complications. This study investigated whether the interaction between depressive symptoms and alcohol frequency was positively related to the development of neuropathy, retinopathy, nephropathy, and coronary artery disease (CAD), such that those with high depressive symptoms and high alcohol frequency will be at increased risk of complications. Methods: Data were from five waves of the Evaluation of Diabetes Treatment annual survey including 1413 adults with T2DM in Quebec. Data on alcohol frequency (number of drinking occasions), depressive symptoms, and complications were collected annually. The development of each complication was investigated using multiple logistic regression analysis with generalized estimating equations. Results: After adjusting for sociodemographic, lifestyle, and diabetes-related covariates, the interaction between alcohol frequency and depressive symptoms was positively related to the incidence of neuropathy and CAD, such that those with high depressive symptoms who drank the most frequently had the highest risk of neuropathy (odds ratio [OR] 1.02, 95% confidence interval [CI] 1.00-1.04; P = 0.04) and CAD (OR 1.02, 95% CI 1.00-1.04; P = 0.04). This interaction was not significantly related to retinopathy or nephropathy. Conclusion: Individuals with high depressive symptoms and high alcohol frequency may have a particularly high risk of neuropathy and CAD. Future prevention efforts should examine both alcohol frequency and depressive symptoms when evaluating the risk of complications.
Introduction
There are approximately 3.5 million people in Canada with diabetes, and approximately 90% of these individuals have type 2 diabetes mellitus (T2DM). 1, 2 Furthermore, approximately 27% of individuals with T2DM have macrovascular complications, and 54% have microvascular complications. 3 Alcohol use in individuals with T2DM is associated with macrovascular and microvascular complications, and these complications can contribute to morbidity and mortality in individuals with T2DM. 4 Heavy alcohol use is associated with an increased risk of macrovascular complications, such as cardiovascular disease, whereas moderate alcohol use is associated with a decreased risk of cardiovascular disease. 5 Conversely, results of studies examining associations between alcohol consumption and microvascular complications, including neuropathy, retinopathy, and nephropathy, are mixed; negative, 6 positive, 7-9 and null 10, 11 associations have been found. In addition, there is some evidence suggesting that moderate alcohol use is related to a decreased risk of retinopathy and nephropathy in type 1 diabetes mellitus (T1DM) and T2DM, 5, 12, 13 and a decreased risk of neuropathy in T1DM. 12 However, additional longitudinal research is necessary to further examine the association between alcohol use and microvascular complications.
When examining the association between alcohol consumption and complications, it may be relevant to consider depression, given that heavy alcohol use is more common in individuals with a high number of depressive symptoms than in the general population. 14 Moreover, high depressive symptoms are more common in individuals with T2DM than in the general population 15 and are associated with complications. 16 Specifically, past research has demonstrated that among individuals with T2DM, those with high depressive symptoms were at an increased risk of developing neuropathy, retinopathy, nephropathy, and heart disease. 17, 18 Heavy alcohol use and high depressive symptoms are often comorbid. 14 There is evidence that high depressive symptoms lead to increased alcohol use, and that chronic alcohol use leads to high depressive symptoms. 19 Given that both heavy alcohol use and high depressive symptoms can increase the risk of complications, individuals who have both may have an even higher risk of complications. However, associations between the combination of alcohol use and high depressive symptoms and the development of complications have not yet been investigated.
There is a lack of previous research on comorbid problems and diabetes-related complications. The aim of the present study was to investigate the longitudinal association of frequency of alcohol use and depressive symptoms on the incidence of diabetes-related complications in a community-based sample of adults with T2DM. It is expected that the interaction between depressive symptoms and alcohol frequency will be positively associated with the development of neuropathy, retinopathy, nephropathy, and coronary artery disease (CAD). Specifically, higher levels of both depressive symptoms and alcohol frequency will be associated with the highest risk of complications. This research could provide valuable information regarding the role of alcohol use and depressive symptoms in the risk and treatment of diabetes complications.
Methods

Sampling strategy
The present study used data from five waves of the longitudinal Evaluation of Diabetes Treatment (EDIT) study, an annual telephone survey across Quebec, Canada. 20 The protocol and informed consent were approved for examinations on depression, diabetes outcomes, diabetes-related complications, sociodemographic characteristics, and clinical and behavioral variables. 20 The inclusion criteria for the EDIT study were adults between 18 and 80 years of age who speak English or French and were insulin-naïve at baseline, with all participants having been diagnosed with T2DM within 10 years before the baseline assessment. Potential participants were contacted through random digit dialing. The present study includes middle-aged and older adult participants who were between 40 and 76 years of age. More detail regarding the sampling strategy can be found in a previous study using EDIT. 20 
Sample
In all, 2028 individuals with T2DM participated in the EDIT study at baseline. The mean (AESD) age was 60.0 AE 8.4 years and approximately half the participants were women. All participants were diagnosed with diabetes within the past 10 years, and most were diagnosed within the past 0-3 years (n = 606). Most participants reported drinking in the past year (n = 958) and the mean (AE SD) depressive symptom score was 4.1 AE 4.9. After excluding those who refused to participate in a follow-up interview (n = 337), 1691 individuals formed the baseline sample. In all, 1413 individuals participated in at least one follow-up assessment (792 individuals in all follow-up assessments, 352 individuals in two follow-up assessments).
Measures
Depression
Depressive symptoms were measured using the Patient Health Questionnaire-9 (PHQ-9) at every wave. 21 This measure includes nine items, each representing a depressive symptom corresponding to the diagnostic criteria for major depression outlined in the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision. 22 Participants rate how often each symptom occurred in the past 2 weeks using a four-point scale from 0 ("not at all") to 3 ("nearly every day"). The scores for each item were summed to provide a total score for each participant, ranging from 0 to 27. 21 This measure demonstrated good internal consistency in the current sample at all assessed time points (α Baseline = 0.813, α Follow-up 1 = 0.842, α Follow-up 2 = 0.818, α Follow-up 3 = 0.841).
Alcohol use
The Alcohol Use Disorders Identification Test-Concise (AUDIT-C) was also administered at every wave and includes three items assessing alcohol consumption and problematic drinking. 23 In the present study, only the item assessing alcohol frequency was used ("How often did you have a drink containing alcohol in the past year?"). 23 The alcohol quantity item was not examined, given that this item assesses quantity on a "typical day," 23 which may be perceived differently for individuals who drink occasionally compared with individuals who drink regularly.
Diabetes complications
The EDIT study included various dichotomous yes/no questions about chronic conditions, with one question assessing nephropathy by asking participants whether they had been diagnosed by a physician with kidney disease. The remaining complications were measured using the Diabetes Complications Index (DCI), a self-report questionnaire that includes 17 dichotomous yes/no items assessing six common diabetes-related complications. 24 Coronary artery disease, the most common type of heart disease, was indicated if participants reported they had been diagnosed with CAD by a physician, had chest pain within the past 6 months, or had been told they had had a heart attack by a physician. Neuropathy was indicated if participants reported numbness in their feet in the past 6 months or loss of bowel control or diarrhea in the past 4 months. Retinopathy was indicated if participants responded that they had been diagnosed with retinopathy or diabetic eye disease by a physician. 24 
Covariates
The following variables, measured at the baseline assessment, were included as covariates in the adjusted model: age, sex, education (less than secondary, secondary, other post-secondary, post-secondary), marital status (married, living as married, never married, divorced or separated, widowed), and duration of diabetes. The use of oral medication for diabetes (yes/no) and smoking status (never, former, current) were time varying and also included as covariates.
Statistical analyses
Longitudinal logistic regression analyses with generalized estimating equations (GEEs) were used to examine associations between frequency of alcohol use, depressive symptoms, and the risk of incident diabetes-related complications. 25 Frequency of alcohol use, depressive symptoms, and complications were all measured at each wave. All statistical assumptions of GEEs were verified before proceeding with the analyses. The GEE uses data from all time points and corrects for the repeated measures of each participant over time. 25 This analysis is advantageous given that individuals who did not respond at the final time point but responded at other follow-up time points can still be included. The autoregressive correlation matrix was specified for the model given that the assessments in EDIT are conducted at equal time intervals of 1 year. 25 In the logistic regression based on GEE, the coefficient for time represents the change in the odds of having complications over time. The coefficient for depressive symptoms assesses the odds of having incident complications as depressive symptoms increase or decrease by 1 unit from 0 to 27. The coefficient for alcohol frequency represents the odds of having incident complications as alcohol frequency increases or decreases by 1 unit. Finally, the coefficient for the interaction of depressive symptoms by alcohol frequency assessed their interaction on the odds of developing incident complications. Significant interactions were examined graphically for interpretation.
Analyses were adjusted for various covariates. The sociodemographic covariates, as well as diabetes duration, were all measured at baseline and are referred to as time-stationary covariates. 25 The use of oral medication and smoking, which were measured at every wave, are referred to as time-varying covariates given that their values could change over time for each participant. 25 Separate models were computed for each of the four complications in order to determine which specific complications are associated with the interaction between alcohol frequency and depressive symptoms. Time, depressive symptoms, and alcohol frequency were entered in the first step of the unadjusted model. The interaction term of depressive symptoms by alcohol frequency was entered in the second step. Finally, all covariates were added to compute the adjusted model. Analyses were conducted using SPSS version 22 (IBM Corp., Armonk, NY, USA) and significant interactions were graphed in STATA version 14 (StataCorp, College Station, TX, USA).
Results
Participant characteristics
Baseline participant characteristics are given in Table 1 . However, the sample for each analysis differed because participants with a particular complication at baseline were excluded from the analyses predicting that complication (see Table 2 ). There was a statistically significant correlation between depressive symptoms and alcohol use frequency at baseline (r = −0.13, P < 0.001), suggesting that a greater number of depressive symptoms at baseline was associated with a lower frequency of alcohol use.
Neuropathy
There was a 9% increase in the odds of developing neuropathy for every unit increase in depressive symptoms, and a 10% decrease in the odds of developing neuropathy for every unit increase in alcohol frequency (see Table 3 ). The interaction between depressive symptoms and alcohol frequency was significantly positively associated with increased odds of developing neuropathy. When the model was adjusted for covariates, the odds of developing neuropathy were no longer significantly related to depressive symptoms. However, the association remained statistically significant for alcohol frequency and for the interaction between depressive symptoms and alcohol frequency.
To visualize the interaction of depressive symptoms and alcohol frequency on the odds of developing neuropathy, predicted probabilities of incident neuropathy were calculated for each combination of depressive symptoms and alcohol frequency. 26 Predicted probabilities are calculated based on the estimated marginal means derived from the model, and provide the estimated probability that an individual, at that particular combination of depressive symptoms and alcohol frequency, will develop neuropathy. 26 The probabilities of neuropathy were then graphed against depressive symptoms and alcohol frequency, using the continuous scales of both the alcohol frequency and depressive symptom measures. 26 As shown in Fig. 1 , individuals with lower depressive symptoms have a lower risk of neuropathy, regardless of alcohol frequency. However, for individuals at higher depressive symptoms, those with higher alcohol frequency levels have a greater probability of neuropathy than those with lower alcohol frequency levels. Finally, those with high depressive symptoms who drank the most frequently had the highest predicted probability of developing neuropathy. Data are presented as the mean AE SD or as n (%). 
Retinopathy
Neither depressive symptoms nor alcohol frequency were significantly associated with the incidence of retinopathy (see Table 3 ). Furthermore, there was no significant interaction between depressive symptoms and alcohol frequency on the odds of developing retinopathy. The adjusted model was similar.
Nephropathy
There was a 6% increase in the odds of developing nephropathy for every unit increase in depressive symptoms, although alcohol frequency was not significantly associated with the incidence of nephropathy (see Table 3 ). There was no significant interaction between depressive symptoms and alcohol frequency on the odds of developing nephropathy. When the model was adjusted for covariates, the odds of developing nephropathy were no longer significantly related to depressive symptoms. However, there was a significant 26% decrease in the odds of incident nephropathy for every unit increase in alcohol frequency. The interaction between depressive symptoms and alcohol frequency on the odds of developing nephropathy remained not significant in the adjusted model.
Coronary artery disease
There was a 9% increase in the risk of developing CAD for every unit increase in depressive symptoms (see Table 3 ). There was no significant association between alcohol frequency and the odds of developing CAD. The interaction between alcohol frequency and depressive symptoms was significantly positively related to increased odds of developing CAD. When the model was adjusted for covariates, the odds of developing CAD were no longer significantly related to depressive symptoms. However, there was an 18% decrease in the odds of developing CAD for every unit increase in Interaction between alcohol frequency and depressive symptoms on the proportion of individuals who developed neuropathy. The curves in the graph reveal how depressive symptoms are associated with the predicted probability of neuropathy for various levels of alcohol frequency (number of drinking occasions as indicated by the 4 response options in the AUDIT-C, ranging from 1 = ≤1 time/month to 4 = ≥4 times/week), and how alcohol frequency is associated with the predicted probability of neuropathy for various levels of depressive symptoms.
alcohol frequency. The interaction between depressive symptoms and alcohol frequency remained positively significantly associated with the incidence of CAD.
The interaction between depressive symptoms and alcohol frequency was graphed to visualize their association with CAD, using predicted probabilities, as for neuropathy. 23 As shown in Fig. 2 , individuals with lower depressive symptoms have a similarly lower risk for CAD, regardless of alcohol frequency. However, for individuals with higher depressive symptoms, those with higher alcohol frequency levels have a greater probability of CAD than those with lower alcohol frequency levels. Finally, individuals with high depressive symptoms who drank the most frequently had the highest risk of CAD.
Discussion
The present study sought to determine whether the interaction between depressive symptoms and frequency of alcohol use would be associated with an increased risk of diabetes-related complications. The hypothesis was partially supported, given that the combination of higher levels of both alcohol frequency and depressive symptoms was associated with the highest risk of incident neuropathy and CAD. Specifically, as shown in Fig. 1 , the predicted probability of neuropathy is between 0.0 and 0.1 for individuals with low depressive symptoms (0-5) at any level of alcohol frequency.
However, at higher levels of depressive symptoms, the predicted probability of neuropathy is dependent on alcohol frequency. For example, a depressive symptom score of 24 is associated with a predicted probability of neuropathy of 0.2-0.3 when alcohol frequency is low, but increases to 0.3-0.5 at higher levels of alcohol frequency. Similarly, as shown in Fig. 2 , the predicted probability of CAD is between 0.0 and 0.2 for individuals with low depressive symptoms (0-5) at any level of alcohol frequency. However, at higher levels of depressive symptoms, the predicted probability of CAD is dependent on alcohol frequency. For example, a depressive symptom score of 24 is associated with a predicted probability of CAD of 0.2-0.3 when alcohol frequency is low, but increases to 0.3-0.4 at higher levels of alcohol frequency. However, this interaction was not significantly related to incident retinopathy and nephropathy. Past research has shown that heavy alcohol use and high depressive symptoms are each independently positively related to neuropathy 7, 17, 18 and heart disease. 5, 17, 18 The present study adds to the literature by demonstrating that the combination of high depressive symptoms and high alcohol frequency may lead to an even greater risk of neuropathy and CAD.
Several possible mechanisms may link alcohol consumption to diabetes-related complications. 4, 5, 27 Whereas acute alcohol consumption may not have any significant long-term effects on glucose in individuals with T2DM, chronic heavy alcohol use may result in changes in glucose levels, insulin resistance, changes in lipid levels, mitochondrial dysfunction, and interference in cell signalling. 4, 5 In addition, individuals with T2DM who drink heavily are also more likely to engage in poorer self-management behaviors, including poorer medication adherence, diet, and exercise, than those who drink less. 24 Through these metabolic, cell signaling, and self-management changes, heavy alcohol use can increase the risk of complications. 4, 5, 27 High depressive symptoms may also increase the risk of complications through poorer diabetes management. 28 Specifically, individuals with T2DM and high depressive symptoms tend to have poorer adherence to medication, diet, and exercise than individuals with T2DM alone. 28 In addition, high depressive symptoms in individuals with T2DM are associated with increased hypothalamic-pituitary-adrenal axis and sympathetic nervous system activation, as well as increased insulin resistance and proinflammatory responses. 29, 30 Through these possible pathways, high depressive symptoms may lead to complications. [28] [29] [30] The interaction between alcohol frequency and depressive symptoms was only associated with increases in the odds of developing neuropathy and CAD, and Interaction between alcohol frequency and depressive symptoms on the proportion of individuals who developed coronary artery disease (CAD). The curves in the graph reveal how depressive symptoms are associated with the predicted probability of CAD for various levels of alcohol frequency (number of drinking occasions as indicated by the 4 response options in the AUDIT-C, ranging from 1 = ≤1 time/month to 4 = ≥4 times/week), and how alcohol frequency is associated with the predicted probability of CAD for various levels of depressive symptoms.
not retinopathy and nephropathy. However, depressive symptoms and alcohol frequency were independently associated with nephropathy, implying that each of their associations does not change depending on the other. Conversely, alcohol frequency and depressive symptoms were not associated with retinopathy. However, it is of note that the sample sizes for retinopathy and nephropathy were smaller than those for neuropathy and CAD. Future research should examine the interaction between alcohol frequency and depressive symptoms on the development of retinopathy and nephropathy in larger samples.
The association of moderate alcohol use with decreased risk of cardiovascular events has been shown previously, 5 although the association of moderate alcohol use with decreased risk of neuropathy has only been found in T1DM. 12 Although moderate alcohol use was not examined in the present study, future research should examine the combination of moderate alcohol use and depressive symptoms on the incidence of complications.
Study strengths and limitations
To the best of our knowledge, the present study is the first to examine the combination of depressive symptoms and alcohol use on the incidence of diabetesrelated complications. All participants were diagnosed with T2DM within the past 10 years, thus the sample was relatively healthy at baseline, making it ideal for examining the development of complications as the illness progresses. In addition, the analyses included a comprehensive list of covariates. Depressive symptoms and alcohol frequency were each measured using reliable and valid questionnaires. 21, 23 Furthermore, past research has shown that the PHQ-9 seems to be a valid measure of depressive symptoms in older adults, 31 and that its telephone administration seems reliable. 32 However, the measures are not clinical assessments and do not measure major depressive disorder or alcohol use disorder, and the interaction between major depressive disorder and alcohol use disorder on diabetes-related complications should be investigated in future studies. In addition, the study spanned 5 years, allowing for the examination of the incidence of complications. However, complications may develop later on as T2DM progresses, thus it would be beneficial for future studies to examine longer time frames in the association between alcohol frequency, depressive symptoms, and complications.
The sample was large and community based, but not necessarily representative. Previous research has found ethnic differences in depressive symptoms 33 and alcohol use 34 in individuals with T2DM, as well as ethnic differences in diabetes-related complications. 35 Accordingly, future research should examine the risk of developing complications for those with high depressive symptoms and high frequency of alcohol use in a sample representative of ethnic diversity.
Although the alcohol use questionnaire used in the present study is reliable and valid, it only provides response options in ranges for alcohol frequency. 23 This does not allow for determination of the specific number of days when drinking frequency is harmful. In addition, some questions in the DCI include a reference interval of 6 months, whereas others have a reference interval of 1 month. 24 The present study also used self-report questionnaires to measure the incidence of complications given that participants were from a community sample and did not provide clinical data. It may be beneficial for future research to replicate this study using a clinical sample.
Conclusion
In conclusion, the combination of high depressive symptoms and high frequency of alcohol consumption was associated with the greatest risk of incident neuropathy and CAD. However, the co-occurrence of alcohol frequency and depressive symptoms on the development of retinopathy and nephropathy should be examined further in a larger sample. Nevertheless, the present results suggest that individuals should be screened not only for frequency of alcohol consumption, but also for depressive symptoms when evaluating the risk of diabetes-related complications, because the combination of high alcohol frequency and high depressive symptoms could lead to an even greater risk of neuropathy and CAD.
